Institute of Nephrology, Shaare Zedek Medical Center, Affiliated with the Hebrew University, Jerusalem, Israel.
Infectious Diseases Unit, Shaare Zedek Medical Center, Affiliated with the Hebrew University, P.O Box 3235, 91031, Jerusalem, Israel.
Eur Geriatr Med. 2024 Feb;15(1):235-242. doi: 10.1007/s41999-023-00861-3. Epub 2023 Sep 15.
The use of a tunneled catheter as the primary vascular access among old hemodialysis patients is frequent. Catheter-related bloodstream infection (CRBSI) is a common complication, associated with increased mortality. Data regarding the clinical presentation and outcomes of CRBSI among old hemodialysis patients is limited.
All chronic hemodialysis patients hospitalized between 2010 and 2022 with CRBSI were included. Patients were classified into two groups: old adults (≥ 75) and younger patients. Clinical, microbiological, and outcome data were collected and analyzed.
One hundred and fifty-four patients with CRBSI were identified. Fifty-seven were aged ≥ 75 years. Mean age in the older and younger groups was 81.2 ± 5 and 59.7 ± 12.7, respectively. Male gender was predominant (64%). Charlson comorbidity score and Pitt bacteremia score were comparable among both groups. Norton score < 14 was more common among old persons (n = 24, 67% versus n = 21, 31%, p < 0.001), as well as nursing-home residence. Gram-negative pathogens and Staphylococcus aureus were common in both groups. The frequency of inappropriate empirical antimicrobial treatment was higher among older persons. Overall, in-hospital and 90-day mortality was high (age ≥ 75, 36.8%, age < 75, 24.7%, p = 0.14). Age was not significantly associated with mortality after adjustment for low Norton score, residence, and inappropriate antimicrobial therapy as well as resistance patterns of bloodstream isolates [OR = 1.2 (95% CI 0.4-3.3), p = 0.76].
Clinical characteristics and outcomes of CRBSI were comparable among old and young hemodialysis patients. However, the high mortality rate in this cohort suggests that the use of tunneled catheters as a permanent vascular access should be discouraged in both patient groups.
在老年血液透析患者中,使用隧道式导管作为主要血管通路较为常见。导管相关性血流感染(CRBSI)是一种常见的并发症,与死亡率增加有关。关于老年血液透析患者 CRBSI 的临床表现和结局的数据有限。
纳入 2010 年至 2022 年期间因 CRBSI 住院的所有慢性血液透析患者。患者分为两组:老年患者(≥75 岁)和年轻患者。收集并分析了临床、微生物学和结局数据。
共确定了 154 例 CRBSI 患者,其中 57 例年龄≥75 岁。老年组和年轻组的平均年龄分别为 81.2±5 岁和 59.7±12.7 岁。男性为主(64%)。两组的 Charlson 合并症评分和 Pitt 菌血症评分相似。Norton 评分<14 在老年人中更为常见(n=24,67%比 n=21,31%,p<0.001),也更常见于疗养院。革兰氏阴性病原体和金黄色葡萄球菌在两组中均很常见。经验性抗菌治疗不当的频率在老年人中更高。总体而言,住院期间和 90 天死亡率较高(年龄≥75 岁,36.8%;年龄<75 岁,24.7%,p=0.14)。在调整了低 Norton 评分、居住地和不适当的抗菌治疗以及血流感染分离株的耐药模式后,年龄与死亡率无显著相关性[比值比 1.2(95%可信区间 0.4-3.3),p=0.76]。
老年和年轻血液透析患者的 CRBSI 临床表现和结局相似。然而,该队列的高死亡率表明,应劝阻在这两个患者群体中使用隧道式导管作为永久性血管通路。